Belarus is losing an estimated $3.38 billion a year through deaths that might have been avoided with effective prevention or treatment delivered in time. The figures, reported by media on 13 November 2026 citing World Health Organization data, put the country at the top of the European regional comparison for the economic cost of treatable mortality.
They also expose a sharp divide within the national picture: among people under 75, the standardised rate of preventable death from non-communicable diseases was almost three times higher for men than for women. The numbers turn missed check-ups, late diagnoses and delayed care into a question not only of public health, but of lost working years, household income and state priorities.
The cost of care that arrives too late
Of the reported total, about $1.35 billion is linked to deaths that could have been avoided through timely medical treatment. That loss is equivalent to 3.8% of gross domestic product, the highest figure in the European region covered by the comparison.
Moldova follows at 3.5% of GDP and Bulgaria at 3.3%. The gap with Switzerland, at about 0.7%, and San Marino, at 0.6%, is considerably wider. Such comparisons do not identify a single cause, nor do they show that one policy decision produced any particular death. They indicate how the combined effects of delayed diagnosis, restricted access, inadequate capacity or treatment that begins after a disease has advanced can accumulate across an economy.
Treatable mortality refers to deaths that might have been prevented if a condition had been detected and managed when medical intervention could still change the outcome. A clinic may exist, yet a patient can still struggle to secure a test, see a specialist or start therapy promptly. The distinction between services being available in principle and care being effective at the decisive moment is central to the figures.
The reported estimate does not assign Belarus’s losses between those possible barriers. It therefore cannot show how much is attributable to infrastructure, waiting times, the availability of specialists, patients’ ability to seek care or other factors. It does show the consequence when the health system reaches people after the window for straightforward treatment has narrowed.
Prevention accounts for the larger share
A further $2.03 billion in annual losses is associated with deaths that prevention might have helped avoid. Belarus ranks second in this category, with losses equivalent to 5.7% of GDP, behind Moldova at 6%.
Prevention includes screening, routine checks, health education and the early management of chronic conditions. It is often less visible than emergency treatment because its success is measured by events that never happen: a cancer found before it becomes advanced, a cardiovascular crisis avoided or an illness kept under control for longer.
When preventive care is weak or difficult to reach, the cost does not disappear. It reappears as premature death, lost income, pressure on relatives and a smaller pool of people able to work. Employers lose years of potential labour; families lose support; public services face demands that earlier intervention might have reduced.
The WHO figures, as reported by the media, do not establish that the Belarusian government directly caused every death or that a particular budget decision explains the full economic loss. They do make it difficult to regard prevention as a secondary item. Together, preventable and treatable mortality represent a burden approaching one-tenth of the country’s economy.
A stark divide between men and women
The overall standardised mortality rate from preventable non-communicable diseases among people younger than 75 was reported at 386.97 cases per 100,000 residents. For men, the rate reached 631.25 per 100,000; for women, it was 211.32.
The male rate was therefore nearly three times the female rate. The figures alone cannot explain the disparity. Working conditions, exposure to health risks, chronic stress, patterns of preventive care and the point at which people seek medical help may all play a part. More evidence would be needed to establish the weight of each factor.
But the difference is too large to treat as a footnote. A national average can conceal groups whose illnesses are diagnosed later or whose contact with the health system is less consistent. Non-communicable diseases often develop over years with few obvious symptoms. If help is sought only when pain, serious disability or a crisis appears, treatment becomes more difficult and the consequences for families and employment grow.
The figures also raise questions about how men engage with healthcare and about the conditions in which they live and work. Those questions cannot be answered by the mortality data alone, but they point towards the need for more targeted prevention and earlier detection rather than relying mainly on hospital care once illness is severe.
Health policy becomes economic policy
Prevention is a difficult investment for governments to display. A screening programme or primary-care appointment produces no dramatic event when it succeeds. Its value lies in avoiding a later emergency, disability or death. That makes underinvestment easier to overlook than a shortage of hospital beds, even though the long-term consequences may be greater.
In Belarus, the reported estimates give those consequences a financial scale. The $3.38 billion is not simply a bill for medical treatment. It represents the economic value associated with lives cut short and years of contribution lost before the age of 75. It also reflects the cost carried by people who must care for relatives after a disease has progressed further than it might have done with earlier help.
That creates a test for the government led by President Alexander Lukashenko, which expects citizens to maintain high levels of work and economic contribution. The expectation cannot be separated entirely from the state’s ability to make prevention, diagnosis and treatment accessible before a manageable condition becomes life-threatening. The available data do not prove that official priorities caused the reported losses, but they show the price of a system that fails to intervene in time.
For Belarus, the immediate challenge is not merely to reduce a headline figure. It is to close the gap between healthcare that exists formally and healthcare that reaches patients early enough to make a difference. Until that gap narrows, the country will continue to lose both economic output and lives to illnesses that, in the reported measure, should not have proved fatal.
Read the reported figures on preventable mortality and economic losses in Belarus.
